PTH was studied for its effects on bone formation in cultured rat calvariae. 0.01-10 nM PTH stimulated [Hjthymidine incorporation into DNA by up to 4.8-fold. Although continuous treatment with PTH for 24-72 h inhibited [3Hlproline incorporation into collagen, transient (24 h) treatment enhanced 1H1-proline incorporation into collagen 24-48 h after the hormone was removed. The collagen stimulated by PTH was type I and the effect was observed in the periosteum-free bone and was not blocked by hydroxyurea. Furthermore, treatment with 1-100 nM PTH for 24 h increased insulin-like growth factor (IGF) I concentrations by two to fourfold, and an IGF I antibody prevented the PTH stimulation of collagen synthesis, but not its mitogenic effect. In conclusion, continuous treatment with PTH inhibits calvarial collagen, whereas transient treatment stimulates collagen synthesis, and the stimulatory effect is mediated by local production of IGF I.
Introduction
Although the regulatory actions of PTH on bone resorption and mineral metabolism are well established, its effects on bone formation are complex and not well characterized (1) (2) (3) . PTH stimulates bone cell replication in vitro, but continuous exposure to PTH results in decreased collagen synthesis in cultured calvariae (4, 5) . In contrast, in vivo studies have shown that PTH increases bone formation (6, 7) . This anabolic effect of PTH seems to be observed mostly after its administration at low or intermittent doses, suggesting that high or continuous doses of PTH cause additional or different effects on bone formation, possibly related to its catabolic actions (6, 8, 9) .
Because the present therapy for osteoporosis is unsatisfactory, there have been clinical trials using PTH for the treatment ofthis disease. Clinical studies indicate that by increasing initial absorption of calcium and by stimulating new bone formation, PTH can restore spinal bone in patients with osteoporosis (7) . However, the discrepancy between the anabolic and inhibitory effects of PTH have not been resolved and the mechanism of the anabolic response is not understood.
The skeletal tissue is a rich source of growth factors and bone cells have been shown to synthesize insulin-like growth factor (IGF)' I, a known stimulator of bone cell replication and matrix synthesis (10) (11) (12) (13) . Because PTH was recently shown to stimulate the synthesis of IGF I in rat osteoblastenriched cells, it is possible that IGF I mediates the anabolic effects of PTH on the skeletal tissue (14) .
These studies were undertaken to characterize the stimulatory and inhibitory actions of PTH on bone formation. For this purpose, we assessed the direct effect of PTH on bone DNA, collagen, and noncollagen protein synthesis in rat calvarial cultures and attempted to determine whether any of these effects were mediated by the local production of skeletal IGF I.
Methods

Culture model
The culture system used was previously described in detail (13) . Briefly, one or two half calvariae from 21-d fetal rats were cultured in sterile 25-ml flasks containing 2 ml of Biggers Gwatkin medium as modified by Fitton Jackson (BGJ) supplemented with 1 mM unlabeled proline, 0.1 mM thymidine, and heat-inactivated (60'C/2 h) BSA (4 mg/ml; Armour Pharmaceutical Co; Kankakee, IL), but no serum. To study effects on IGF I concentrations, calvariae were cultured in the absence of albumin or serum. The flasks were gassed with 5% CO2 in air, sealed, and placed in a continuously shaking water bath at 370C for a 24-h pre-culture period. Calvariae were then cultured in control or test medium for an additional 24-72-h period. Rat synthetic 1-34 PTH (Calbiochem-Behring Corp., La Jolla, CA) and hydroxyurea (Sigma Chemical Co., St. Louis, MO) were added directly to BGJ medium. A neutralizing-monoclonal K IgG antibody to human IGF I, which had some cross-reactivity with IGF II, and was kindly provided by J. J. Van Wyk (University of North Carolina, Chapel Hill, NC) (15) , and a monoclonal K IgG antibody against a thymocyte surface antigen (T-8) generated under the same conditions and kindly provided by B. Haynes (Duke University, Durham, NC) were tested at a 1: 1,000 dilution and added directly to BGJ medium. At this dilution the IGF I antibody has been shown to be neutralizing (15) in other systems and to block the effect of added IGF I (10 nM) on calvarial DNA and collagen synthesis (data not shown).
DNA synthesis DNA synthesis was studied by examining effects on [3Hjthymidine incorporation into DNA. [methyl-3H]Thymidine (5 ACi/ml; specific activity 60-80 Ci/mmol; New England Nuclear, Boston, MA) was added during the last 60 min of the culture period. Calvariae were washed with cold 5% TCA, acetone, and ether; the bones were then dried and weighed and the incorporated radioactivity was determined after digesting them with NCS tissue solubilizer (Amersham Corp., Arlington Heights, IL). Data are expressed as disintegrations per minute per microgram dry weight or as percent of control after dry weight correction.
Histology and mitotic index
To study effects on cell mitosis, calvariae were cultured and N-deacetyl-N-methylcolchicine (Colcemid, 4 X 10-6 M; Gibco Laboratories, Grand Island, NY) was added for the last 3 h of the culture period. Calvariae were fixed in neutral formalin, embedded in paraffin, stained with hematoxylin-eosin and sections examined at a magnification of 250-400. Metaphase-arrested cells were counted in at least two random cross-sections taken from control or treated bone explants. Data are expressed as number of mitoses/section of half calvaria.
Collagen and noncollagen protein synthesis
Effects on newly synthesized collagen were determined by studying the incorporation of [2,3-3H] proline (specific activity 25-40 Ci/mmol; New England Nuclear) into total collagen and into type I collagen.
Labeled proline (5 ACi/ml for total and 50 MCi/ml for type I collagen experiments) was added for the last 2 h of the culture period.
(a) Total collagen synthesis. Calvariae were extracted as described for DNA labeling and homogenized in 0.5 M acetic acid. An aliquot was incubated with repurified bacterial collagenase (CooperBiomedical, Inc., Malvern, PA) and the labeled proline was incorporated into collagenase-digestible protein (CDP) and noncollagen protein (NCP) was measured according to the method of Peterkofsky and Diegelmann (16) . Data are expressed as disintegrations per minute per microgram dry weight or as percent ofcontrol after dry weight correction. Percent collagen synthesis was calculated after multiplying NCP by 5.4 to correct for the relative abundance of proline in collagen and noncollagen protein ( 17).
(b) Type I collagen synthesis. Calvariae were rinsed with saline (9 g/liter NaCl), homogenized as a pool in 0.5 M acetic acid, digested with 1 mg/ml pepsin (Sigma Chemical Co.) over a 12-16 h period at 4VC and neutralized with sodium hydroxide. An aliquot representing one half calvaria and a radioactive type I collagen standard was dissolved in sample buffer and the collagen chains were separated on a 6% polyacrylamide gel, according to a modification ofthe method described by Sykes et al. (18) . 2-Mercaptoethanol was applied to half ofthe samples 60 min after the electrophoresis was started (reduced collagen), whereas the other half was not treated (unreduced collagen). At the completion of the electrophoresis, the gels were fixed and the protein profiles were displayed by fluorography.
Effects on periosteum and periosteum-free calvaria
These experiments were performed to compare effects on periosteal tissue, rich in fibroblasts and osteoprogenitor cells, with those on the central calvaria which is rich in osteoblasts (19, 20) . Intact bones were cultured and [3Hlthymidine or [3Hlproline was added for the last 60 or 120 min of the incubation period, respectively. Calvariae were washed with saline and the periosteum was removed from the superior and inferior surfaces ofthe bone with a scalpel blade. (Fig. 1) . The effect was observed at concentrations as low as 0.01 nM, and at 10 nM PTH increased DNA labeling by 4.8-fold. Treatment with PTH at 1 nM for 24 h increased the number of metaphase-arrested cells after colcemid treatment from a control value of (mean±SE; n = 4) 3.5±0.6 to 6.3±0.7 mitoses/section (P < 0.05), a stimulation that was observed only in the periosteal layer.
Collagen and noncollagen protein synthesis proline into CDP and to a lesser extent into NCP; therefore, the percent ofcollagen synthesized was decreased (Fig. 2) . The inhibitory effect of PTH was observed at doses as low as 1 pM, and at 0.1 nM it decreased the labeling ofCDP by -50%. The inhibitory effect of PTH on the incorporation of [3H]proline into CDP was observed only after continuous exposure to the hormone and was detected for a 72-h period of treatment (Fig.  3) . The dose response curve was similar after 24 or 72 h of continuous PTH treatment, and at 72 h PTH concentrations of 1O pM to 10 nM inhibited CDP labeling by 28-44% and the percent of collagen synthesized by 19-45%, indicating that the inhibitory effect of PTH was more selective for collagen. In addition, the effect was observed in the presence ofa concomi- (Fig. 4) . Virtually all the collagen synthesized by control and treated calvariae comigrated on PAGE with a rat type I collagen standard. (Fig. 5) .
DNA synthesis rates were higher in the periosteum and collagen synthesis rates were higher in the periosteum-free, osteoblast-rich, bone ofcontrol calvariae (Table II) (Table IV) . In contrast, the IGF I antibody prevented the increase in [3H]proline incorporation into CDP observed after transient exposure to PTH (Table IV) .
Discussion
These studies were undertaken to examine the effects of continuous and transient PTH synthesis and increased the number of colcemid-induced metaphase-arrested cells. The mitogenic effect of PTH occurred in the periosteal layer, but calvariae contain a mixed cell population and the cells affected could not be precisely identified. These cells did not appear to include differentiated osteoblasts, and osteoblast-enriched cell cultures from rat calvariae are not mitogenically responsive to PTH (21). The relevance of the mitogenic effect is not clear because neither the continuous nor the transient effect of PTH on collagen synthesis was modified in the presence of the DNA synthesis inhibitor hydroxyurea, indicating that the changes in collagen synthesis were independent ofthe mitogenic actions ofPTH. Previous studies also have shown that the effect of PTH on bone resorption is independent of that on DNA synthesis (22). The mechanism of action of the mitogenic effect of PTH is unknown and antibody neutralization studies indicate that IGF I does not appear to mediate this effect. It is possible that other local regulators of bone remodeling, such as transforming growth factor ,B (TGFj3), are mechanistically relevant to the mitogenic actions of PTH because TGFB is a potent mitogen for bone cells and PTH regulates the binding ofTGFB to its receptor (21, 23, 24).
Continuous treatment with PTH for 24-72 h resulted in an inhibition ofbone collagen synthesis, and this observation is in agreement with previous reports (5). In contrast, transient treatment with PTH resulted in an increase in bone collagen synthesis. The collagen synthesized was type I and the effect was observed in the periosteal-free bone, suggesting that PTH stimulated osteoblast collagen synthesis. This effect was not related to the mitogenic actions of PTH, as it was not modified by hydroxyurea, and it is possible that PTH acted on differentiated osteoblasts or on the differentiation of preosteoblastic The results observed with PTH are similar to those observed with IGF I, which is known to stimulate osteoblast-collagen synthesis and matrix apposition rates independent of its mitogenic actions (13) . It is reasonable to believe that the stimulatory effect of PTH on bone collagen synthesis is mediated by IGF I because the two agents have similar effects, PTH stimulates IGF I synthesis, and IGF I-neutralizing antibodies prevent the enhancement of calvarial collagen synthesis by PTH. Since the IGF I-neutralizing antibody cross-reacts to some extent with IGF 11 (15) , it is conceivable that the collagen (25, 26) , so that in either instance PTH would act through the same mechanism. It is likely that the local production ofIGF I is important in the coupling of bone formation to bone resorption (27) . PTH stimulates both bone resorption and the synthesis of IGF I, and this newly synthesized IGF I could be important in the formation of new bone.
Previous observations have indicated that IGF I mediates the effects ofgrowth hormone on bone formation (28) , and our studies confirm that local-skeletal factors act as intermediaries of hormonal action because IGF I mediates the anabolic effects of PTH. Our investigations also provide an explanation for some of the previously reported discrepancies between the stimulatory and inhibitory effects of PTH on bone collagen synthesis and confirm that the anabolic effect of PTH is primarily observed after intermittent treatment (6, 8, 9) . Since collagen is the major component of the bone matrix, it is reasonable to expect that changes in bone formation would parallel those on collagen synthesis. It is unclear why continuous exposure to PTH results in an inhibition of collagen synthesis despite increased IGF I concentrations, but our previous studies have shown that continuous treatment with PTH opposes the stimulatory activities of IGF I on collagen synthesis (12) . It is therefore apparent that PTH overrides the IGF I-dependent stimulation, possibly by modifying specific osteoblast-differentiated functions. Although the mechanism of the inhibitory effect of PTH is not known, based upon this and previous reports (6, 8, 9) , it would seem appropriate to use intermittent instead of continuous PTH in therapeutic trials for osteoporosis.
In conclusion, continuous treatment of rat calvarial cultures with PTH results in an inhibition of collagen synthesis, whereas transient treatment stimulates collagen synthesis, and this effect appears secondary to the local production of skeletal IGF I.
